Utah Medical Products, Inc.

How big is Utah Medical Products, Inc.?

As of Jun 18, Utah Medical Products, Inc. has a market capitalization of 175.34 million, with net sales of 39.28 million and a net profit of 12.95 million over the latest four quarters.

Market Cap: As of Jun 18, Utah Medical Products, Inc. has a market capitalization of 175.34 million, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, the company reported net sales of 39.28 million and a net profit of 12.95 million.<BR><BR>Balance Sheet Snapshot: As of Dec 24, the company reported shareholder's funds of 117.43 million and total assets of 122.54 million.

What does Utah Medical Products, Inc. do?

Utah Medical Products, Inc. manufactures disposable medical devices for hospitals and is classified as a micro-cap company with a market cap of $175.34 million. As of March 2025, it reported net sales of $10 million and a net profit of $3 million.

Overview:<BR>Utah Medical Products, Inc. is engaged in producing disposable medical devices for hospital use, operating within the Pharmaceuticals & Biotechnology industry and classified as a micro-cap company.<BR><BR>Financial Snapshot:<BR>- Most recent Net Sales: 10 Million (Quarterly Results - Mar 2025)<BR>- Most recent Net Profit: 3 Million (Quarterly Results - Mar 2025)<BR>- Market-cap: USD 175.34 Million (Micro Cap)<BR><BR>Key Metrics:<BR>- P/E: 14.00<BR>- Dividend Yield: 188.39%<BR>- Debt Equity: -0.71<BR>- Return on Equity: 11.07%<BR>- Price to Book: 1.50<BR><BR>Contact Details:<BR>- Address: 7043 S Cottonwood St, MIDVALE UT : 84047-1048<BR>- Tel: 1 801 5661200<BR>- Website: http://www.utahmed.com

Should I buy, sell or hold Utah Medical Products, Inc.?

Who are in the management team of Utah Medical Products, Inc.?

As of March 2022, the management team of Utah Medical Products, Inc. includes Kevin Cornwell (Chairman, President, CEO, Secretary), Ernst Hoyer (Lead Independent Director), Paul Richins (Director), Dr. James Beeson (Independent Director), and Dr. Barbara Payne (Independent Director).

As of March 2022, the management team of Utah Medical Products, Inc. includes Mr. Kevin Cornwell, who serves as the Chairman of the Board, President, Chief Executive Officer, and Secretary. Other members of the management team are Mr. Ernst Hoyer, the Lead Independent Director; Mr. Paul Richins, a Director; Dr. James Beeson, an Independent Director; and Dr. Barbara Payne, also an Independent Director.

Is Utah Medical Products, Inc. overvalued or undervalued?

As of July 7, 2025, Utah Medical Products, Inc. is considered undervalued with attractive valuation metrics, despite recent stock performance lagging behind the S&P 500, indicating a potential investment opportunity.

As of 7 July 2025, the valuation grade for Utah Medical Products, Inc. has moved from expensive to attractive, indicating a shift in perception regarding its value. The company appears undervalued, supported by a P/E ratio of 14, an EV to EBIT of 7.70, and a Price to Book Value of 1.56. In comparison, its peer CareDx, Inc. has a significantly higher P/E ratio of approximately 27.91, while Tactile Systems Technology, Inc. shows an EV to EBITDA of 9.59, further illustrating Utah Medical's relative valuation appeal.<BR><BR>Despite the attractive valuation, Utah Medical's recent stock performance has lagged behind the S&P 500, with a 1-year return of -5.62% compared to the S&P 500's 17.14%. This underperformance over the longer term, particularly a 3-year return of -26.66% versus the S&P 500's 70.41%, may raise concerns among investors, but the current valuation metrics suggest that the stock could be a compelling opportunity.

Is Utah Medical Products, Inc. technically bullish or bearish?

As of September 11, 2025, Utah Medical Products, Inc. shows a bullish technical trend with positive momentum indicators across multiple timeframes, having returned 11.01% over the past month, outperforming the S&P 500's 2.33%, despite a 1-year underperformance of -5.62% compared to the S&P's 17.14%.

As of 11 September 2025, the technical trend for Utah Medical Products, Inc. has changed from sideways to bullish. The weekly MACD is bullish, and the monthly MACD is mildly bullish, indicating positive momentum. Bollinger Bands are bullish for both weekly and monthly periods, reinforcing the bullish stance. Daily moving averages also confirm a bullish trend. The KST is bullish weekly and mildly bullish monthly, while the Dow Theory shows a mildly bullish stance on the monthly timeframe. <BR><BR>In terms of performance, the stock has returned 11.01% over the past month, significantly outperforming the S&P 500's 2.33% return, but it has underperformed over longer periods, such as the 1-year return of -5.62% compared to the S&P 500's 17.14%. Overall, the current technical stance is bullish, with moderate strength indicated by multiple bullish signals across different timeframes.